Miami pharma exec, a big Republican donor, agrees to pay up to $50 million to settle Medicaid civil fraud charges
Nostrum Laboratories' carton label on its "Nitro OS" antibacterial medicine. The Justice Department says that Nostrum and CEO Nirmal Mulye have agreed to pay millions to settle civil claims they knowingly underpaid required Medicaid rebates. By Dan Christensen, FloridaBulldog.org A Miami businessman who once justified his decision